Skip to main content

MoneyWorks4Me

Lupin informs about press release

18 Jan 2023 Evaluate
Lupin has informed that it enclosed a Press Release as regards launch of launch of combination drug Sacubitril and Valsartan under two brand names, Valentas and Arnipin for patients with Heart Failure conditions. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1764.30
Dr. Reddys Labs. 1315.75
Cipla 1343.50
Lupin 1951.20
Zydus Lifesciences 1170.00
View more..